Cargando…
Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications
The LC16m8 strain of vaccinia virus, the active ingredient in the Japanese smallpox vaccine, was derived from the Lister/Elstree strain. LC16m8 is replication-competent and has been administered to over 100,000 infants and 3,000 adults with no serious adverse reactions. Despite this outstanding safe...
Autores principales: | Kidokoro, Minoru, Shida, Hisatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494248/ https://www.ncbi.nlm.nih.gov/pubmed/26344890 http://dx.doi.org/10.3390/vaccines2040755 |
Ejemplares similares
-
Combined Cytolytic Effects of a Vaccinia Virus Encoding a Single Chain Trimer of MHC-I with a Tax-Epitope and Tax-Specific CTLs on HTLV-I-Infected Cells in a Rat Model
por: Ohashi, Takashi, et al.
Publicado: (2014) -
SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
por: Kitabatake, Masahiro, et al.
Publicado: (2007) -
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain
por: Eto, Akiko, et al.
Publicado: (2021) -
A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine
por: Sakamoto, Akihiko, et al.
Publicado: (2022) -
A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome
por: Yoshikawa, Tomoki, et al.
Publicado: (2021)